v3.21.2
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating activities:    
Net loss $ (8,771) $ (3,364)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 492 618
Loss on disposal of property and equipment 3 0
Stock-based compensation 1,155 409
Accretion of debt discount and issuance costs 33 20
Decrease in fair value of derivative liability (37) (105)
Increase (decrease) in fair value of warrant liability (1,375) 398
Deferred income taxes 0 9
Changes in operating assets and liabilities:    
Receivables (1,802) 3,685
Contract assets (238) (140)
Income taxes receivable / payable 221 (184)
Prepaid expenses and other assets (105) 394
Accounts payable and other accrued liabilities (242) 1,030
Accrued compensation (1,305) 177
Deferred revenue (3,724) 3,709
Increase (Decrease) in Other Operating Liabilities 0 151
Net cash used in operating activities (11,615) (283)
Investing activities:    
Purchases of property and equipment (216) (29)
Net cash used in investing activities (216) (29)
Financing activities:    
Principal payments on financing obligations (219) (185)
Principal payment on line of credit (1,840) 0
Proceeds from line of credit 1,840 0
Principal payment on term loan (1,833) 0
Net proceeds from common stock issuance 23,085 0
Proceeds from issuance of common stock under employee stock plans 226 0
Common stock repurchases to settle employee withholding liability (6) (54)
Net cash provided by (used in) financing activities 21,253 (239)
Effect of exchange rate changes on cash 28 (201)
Net increase (decrease) in cash and cash equivalents 9,450 (752)
Cash and cash equivalents, beginning of period 11,878 10,639
Cash and cash equivalents, end of period 21,328 9,887
Supplemental disclosures of net cash paid (received) during the period:    
Income taxes, net (413) 27
Interest, net 31 7
Non-cash financing activity:    
Issuance of note payable and derivative liability for cancellation of warrant 0 1,855
Reclassification from warrant liability to additional paid-in capital for non-cash exercise $ 560 $ 0

Source